Recently, the 2026 "Hand in Hand with Beijing-Tianjin-Hebei · Overseas Chinese Wisdom Gathering in Xiong'an" and New Overseas Chinese Innovation and Entrepreneurship Conference, guided by the Economic and Technological Department of the All-China Federation of Returned Overseas Chinese and co-hosted by the Hebei, Beijing, and Tianjin Federations of Returned Overseas Chinese, along with the Xiong'an New Area Party Working Committee, was grandly held in Xiong'an New Area, Hebei. As a technology-driven CDMO (Contract Development and Manufacturing Organization) enterprise, Laviana Pharma was invited to attend this grand event, gathering with overseas Chinese academicians, experts, scholars, and industry elites from 10 countries and regions to jointly discuss the gathering of overseas Chinese wisdom in Xiong'an and plan for a new industrial future.

Themed "Overseas Chinese Gather in Xiong'an, Innovating for the Future," the conference aimed to attract high-level overseas Chinese talents and innovation teams to invest and start businesses in Xiong'an, aligning with the area's industrial positioning. During the conference, top experts, including Chinese-American supercomputer expert Chen Shih-ching and Japanese Academy of Engineering member Feng Demin, delivered keynote speeches on cutting-edge fields such as the digital economy, advanced manufacturing, and global biopharmaceutical trends. This provided deep intellectual support for the industrial upgrading and the construction of the science and innovation system in the new area. Representatives from Laviana Pharma fully participated in the opening ceremony, keynote speeches, and thematic visits such as "Seeing Xiong'an, Witnessing the New City," where they toured key areas and industrial platforms in Xiong'an, gaining a firsthand understanding of the area's rapid development and the policy support for "high-precision and advanced" technology projects.

As an invited overseas Chinese enterprise and a representative company in the biopharmaceutical field, Laviana Pharma engaged in in-depth exchanges and docking with multiple parties during the event. Leveraging efficient communication platforms built by the conference, such as the "Overseas Chinese Enterprises Entering Parks, Win-Win Cooperation" Project Matchmaking Conference and the "Overseas Chinese Wisdom Science and Innovation Supermarket," Laviana Pharma actively explored the industrial resources and supporting policies of parks like the Xiong'an New Area Zhongguancun Science and Technology Park, seeking precise alignment between innovation elements and its own industrial needs. Possessing deep technical expertise in fields such as custom synthesis of API intermediates, innovative drug CMC services, and formulation and analytical research, this participation not only broadened the company's strategic vision but also laid a solid foundation for further optimizing its industrial layout and expanding domestic and international markets, leveraging the collaborative development of the Beijing-Tianjin-Hebei region and the policy dividends of Xiong'an New Area.

This invitation to participate deeply impressed upon us the strategic positioning and development momentum of Xiong'an New Area as one of Beijing's new "two wings," particularly the policy strength and resource endowment in the biopharmaceutical industry layout. Laviana Pharma will fully leverage the group's locational advantages in the Beijing-Tianjin-Hebei region—with the Tianjin R&D Innovation Center as the technology source and the Cangzhou GMP production base as the industrialization support—proactively align with Xiong'an New Area's industrial ecosystem, continuously deepen cooperation with domestic and international innovative drug companies and overseas Chinese science and innovation projects, and actively integrate into the national strategy of Beijing-Tianjin-Hebei collaborative development.

Looking to the future, Laviana Pharma will take this conference as an opportunity to further seize the strategic opportunities for the construction of Xiong'an New Area, continuously increase investment in both R&D and production, deepen the application of cutting-edge technologies such as AI and automation in pharmaceutical R&D, empower industrial upgrading with innovative technologies, contribute to the high-quality development of the Beijing-Tianjin-Hebei biopharmaceutical industry, and join hands with overseas Chinese colleagues at home and abroad to write a new innovative chapter for the future city of Xiong'an.